Deaths of New-Born Babies have hit Critical Levels; Increases in Ovarian Cancer: Excess Mortality Among Children After Vaccine Rollout – Official Data

Depopulation & WW3
,
1

image

Official Data shows huge increase in cases of Ovarian Cancer, and Deaths of New-Born Babies have hit Critical Levels; are the Covid-19 Vaccines to blame?

Data available from Public Health Scotland shows that cases of ovarian cancer in 2021 are much higher than the 2017-2019 average, and deaths of new-born babies have reached the upper warning threshold indicating factors beyond random variation may have contributed to the deaths.

With nearly 40,000 menstrual disorders being reported as adverse reactions to the Covid-19 vaccines, scientists warning of potential issues with the formulation of the Covid-19 injections leading to infertility, real-world data showing the rate of miscarriage following Covid-19 vaccination is as high as 82%, and a confidential study showing the Covid-19 vaccine accumulates in the ovaries over time, could the rise in ovarian cancer and deaths of new-born babies have anything to do with the mass roll-out of the Covid-19 vaccines?

Continued at link.

Great Britain: Excess Mortality Among Children After Vaccine Rollout

https://rairfoundation.com/great-britain-excess-mortality-among-children-after-vaccine-rollout/

Is it just a coincidence that deaths among children have increased by 62% since the rollout of the mRNA shots (up to 400% in vulnerable children) against the five-year average?

Deaths of children have been on the rise since the UK started vaccinating teenagers from the age of 12 and older. The risk-benefit analysis raises serious doubts about injecting this age group with the experimental drug.

On September 20, the British national health service NHS announced that the coronavirus vaccine would be rolled out for children aged 12 to 15. In part of the biggest vaccination drive in the country’s health service history, nearly three million children can receive a first dose of the Pfizer vaccine. According to the NHS, jabs started in hundreds of schools (week 38), with the injection program rolling out to others in the coming weeks.

Continued at link.

Children Become The Next Target For The Jab

Life or Death: Pharmaceutical “Plandemic” Poisonous Vaccines, or the Healing of the Holy Spirit – Your choice

6 Likes
2

WHO Issues Warning on “Unusual” Surge of Severe Myocarditis Cases in Newborns and Infants

By Jim Hoft May. 20, 2023

image
image1024×684 24.3 KB

The World Health Organization (WHO) has sounded the alarm over a significant increase in cases of “severe myocarditis” among newborns and infants in Wales and England.

The WHO issued a warning on Tuesday, drawing attention to a worrying increase in these severe cases of myocarditis between June 2022 and March 2023 and recommending increased awareness and further investigation into the underlying causes.

“On 5 April 2023, the National IHR Focal Point for the United Kingdom informed WHO of an increase in severe myocarditis in neonates associated with enterovirus infection in Wales,” according to the news release. There were ten newborns hospitalized with myocarditis, and one of them died.

Conservatives Are Looking For Ways To Boycott and Move Spending Away From Woke Corporations -- Here Is One Way To Do It

“Between June 2022 and April 2023, ten hospitalized neonates with a positive enterovirus Polymerase Chain Reaction (PCR) test were found to have myocarditis. Seven of the ten cases had further subtyping, with either coxsackie B3 or coxsackie B4 identified. As of 5 May 2023, one patient was still hospitalized, and one had died.”

According to a UK Health Security Agency (UKHSA) representative who spoke with The Epoch Times, there were also five cases of myocarditis in England.

Myocarditis, an inflammation of the heart muscle, can lead to significant complications and, in severe cases, even result in heart failure. Typically, enterovirus infections in neonates and young infants tend to be mild and self-limiting. However, the recent surge in severe myocarditis cases with adverse outcomes in this population is highly unusual and warrants immediate attention.

“Although enterovirus infections are common in neonates and young infants, the reported increase in myocarditis with severe outcomes in neonates and infants associated with enterovirus infection is unusual,” said WHO.

WHO added that epidemiological investigations are ongoing.

More from the WHO’s news release:

On 5 April 2023, the National IHR Focal Point for the United Kingdom informed WHO of an increase in severe myocarditis in neonates and infants associated with enterovirus infection in Wales.

Between June 2022 and April 2023, ten neonates, under 28 days of age, presented with a picture consistent with myocarditis and a positive enterovirus PCR. Seven cases were treated in intensive care, and one case died before transfer to tertiary care. Cases presented with features of sepsis, myocarditis, or in cardiorespiratory arrest. The peak incidence of cases was in November 2022, with sporadic cases in other months.

Enterovirus PCR testing of all ten cases (with either blood, throat swab, nose swab, nasopharyngeal aspirate or cerebrospinal fluid samples) confirmed the presence of an enterovirus, subtyping (where available) to either coxsackie B3 or coxsackie B4.

Critical care support including intubation, ventilation and circulatory support was given to the patients who went to intensive care.

As of 5 May 2023, one patient was still hospitalised and one had died.

The reported increase in severe myocarditis in neonates and infants associated with enterovirus infection is unusual. In the tertiary hospital covering the South Wales region, two other similar cases have been identified in the 6 years prior to June 2022.

A further five cases have been identified over the same period in the Southwest of England. No additional information is currently available about these cases. Details of five of the cases from South Wales and three of the additional cases from Southwest England have recently been published (Ng et al., 2023).